INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "REMIBRUTINIB DRUG SUBSTANCE AND DRUG PRODUCT SUBSTANTIALLY FREE OF NITROSAMINE IMPURITY"

GENEVA, Aug. 4 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/050760) for "REMIBRUTINIB DRUG SUBSTANCE AND DRUG PRODUCT SUBSTANTIALLY FREE OF NITROSAMINE IMPURITY" on Jan 24, 2025. With publication no. WO/2025/158336, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CESAR, JoZko (Novartis farmacevtska proizvodnja d.o.o. Verovskova ulica 571000 Ljubljana), FLEURY, Christian Roger Claude (Novartis Pharma AGLichtstrasse 354056 Basel), KLANG, Thorsten (Novartis Pharma AGLichtstrasse 354056 Ba...